Bio Pharma Dive
JUNE 10, 2024
Of the changes sparked by value-based care, perhaps the most valuable for the biopharmaceutical industry to embrace is the use of health economics and outcomes research (HEOR) to better understand a product’s value.
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by Aligos Therapeutics for compounds targeting hepatitis B and D. Learn about the innovative methods for treatment and synthesis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JUNE 10, 2024
Positive results from the trial could position Moderna to bring the two-in-one vaccine to market in 2025.
Pharmaceutical Technology
JUNE 10, 2024
SNS-101 is a monoclonal antibody commercialized by Sensei Biotherapeutics, with a leading Phase II program in Non-Small Cell Lung Cancer.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
JUNE 10, 2024
The expert committee concluded donanemab’s benefits outweigh its risks, despite some concern over the drug’s safety.
Pharmaceutical Technology
JUNE 10, 2024
PYX-201 is a monoclonal antibody conjugated commercialized by Pyxis Oncology, with a leading Phase I program in Thyroid Cancer.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JUNE 10, 2024
Clinical trial supply chains have experienced significant changes in recent years. We identify the four key trends.
Bio Pharma Dive
JUNE 10, 2024
The MilliporeSigma viral vector team has unlocked unique insights and workflows that can guide innovators through steps they might not even realize they needed to take.
Pharma Times
JUNE 10, 2024
Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK
Pharmaceutical Technology
JUNE 10, 2024
All eleven members of an FDA advisory committee voted yes in favour of approving Lilly’s donanemab for the treatment of Alzheimer’s disease.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
JUNE 10, 2024
Accounting for 4% of all cases, kidney cancer is currently the sixth most common cancer diagnosed in the UK
Pharmaceutical Technology
JUNE 10, 2024
Boehringer and Zealand have shared new data that builds on previously announced results with survodutide in MASH.
Antidote
JUNE 10, 2024
Also known as endometrial carcinoma or uterine cancer, endometrial cancer occurs when the cells that line the uterus begin growing uncontrollably. Though the mortality rates are relatively low due to the high rate of early detection, it is a cancer that impacts nearly 70,000 people every year.
Pharmaceutical Technology
JUNE 10, 2024
Eisai and Biogen eye expanded regimen options for thire Alzheimer’s disease drug, as experts debate the reach of Eli Lilly’s donanemab.
pharmaphorum
JUNE 10, 2024
Discover how pharmaceutical companies can leverage digital technologies to accelerate innovation and disrupt the industry. Learn about regulatory considerations and engagement with healthcare professionals (HCPs) for successful digital transformation.
Pharmaceutical Technology
JUNE 10, 2024
Ipsen has expanded its ongoing oncology research partnership with Marengo Therapeutics to advance precision precision T cell engagers (TCE).
pharmaphorum
JUNE 10, 2024
Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro, with a lower BMI threshold than draft NICE guidance
Pharmaceutical Technology
JUNE 10, 2024
Discover Kodiak Sciences Inc's innovative method for treating wet age-related macular degeneration with an anti-VEGF antibody conjugate. Patented approach offers extended therapeutic effects for at least 12 weeks, providing a less frequent treatment option.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
FDA Law Blog
JUNE 10, 2024
By Sarah Wicks & Anne K. Walsh — Among FDA-regulated establishments and stakeholders, there is one word that makes everyone go on edge – the dreaded FDA “inspection.” In an effort to clarify for industry and alleviate some of the stress associated with these activities, last week the FDA issued a draft guidance aimed at providing recommendations on how to handle inspections under FDA’s Bioresearch Monitoring (BIMO) program.
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by Ikena Oncology Inc for treating cancer with specific compounds and compositions. Learn about the innovative method targeting TEAD expression and YAP localization in various types of cancer.
Drug Patent Watch
JUNE 10, 2024
In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden.
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by Tenaya Therapeutics Inc for compounds inhibiting HDAC6 activity, offering potential treatments for various diseases. Explore the detailed chemical formula and structural insights in this comprehensive overview.
pharmaphorum
JUNE 10, 2024
The last three slots for projects that will be included in the FDA’s new programme to accelerate the development of therapies for rare diseases have been taken by Moderna, Myrtelle, and Calico Life Sciences.
Pharmaceutical Technology
JUNE 10, 2024
Discover Vir Biotechnology's groundbreaking patent for a monoclonal antibody targeting Staphylococcus aureus infections. Learn how this innovative composition binds to key proteins for potential treatment.
BioSpace
JUNE 10, 2024
Moderna’s combination vaccine candidate for COVID-19 and influenza outperformed licensed vaccines in older adults, according to late-stage results reported on Monday.
Pharmaceutical Technology
JUNE 10, 2024
Discover how AbCellera Biologics Inc's patented transgenic mouse with a unique LDH expression cassette revolutionizes immunoglobulin library production, enabling extended HCDR3 regions. Explore the groundbreaking genetic modifications enhancing antibody engineering.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
JUNE 10, 2024
LSD, ketamine, ibogaine and related treatments are moving forward in clinical trials for substance use disorders, including alcohol use disorder and opioid use disorder.
Pharmaceutical Technology
JUNE 10, 2024
Discover the groundbreaking patent by RAPT Therapeutics Inc for pyrazole pyrimidine compounds targeting HPK1, offering hope for treating cancer and other diseases. Explore the wide-ranging potential of this innovative compound today!
BioPharma Reporter
JUNE 10, 2024
AbbVie has announced that the Scottish Medicines Consortium (SMC) has approved Tepkinly (epcoritamab) for adults with diffuse large B-cell lymphoma (DLBCL) who have not responded to or have relapsed after at least two prior treatments.
Pharmaceutical Technology
JUNE 10, 2024
Moderna has filed an application with the US FDA to review its updated Spikevax formula, designed to combat the SARS-CoV-2 variant JN.1.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
263 
Let's personalize your content